Enveric Biosciences Stock (NASDAQ: ENVB) stock price, news, charts, stock research, profile.
Open | $0.48 |
Close | $0.47 |
Volume / Avg. | 617.88K / 555.58K |
Day Range | 0.46 - 0.54 |
52 Wk Range | 0.41 - 3.90 |
Market Cap | $3.74M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 34 |
Short Interest | 1.67% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Enveric Biosciences (NASDAQ:ENVB) through any online brokerage.
Other companies in Enveric Biosciences’s space includes: Cingulate (NASDAQ:CING), Biofrontera (NASDAQ:BFRI), NovaBay Pharmaceuticals (AMEX:NBY), Processa Pharma (NASDAQ:PCSA) and Titan Pharma (NASDAQ:TTNP).
There is no analysis for Enveric Biosciences.
Enveric Biosciences has a consensus price target of $3.82.
The stock price for Enveric Biosciences (NASDAQ: ENVB) is $0.4701 last updated July 25, 2024 at 7:46 PM EDT.
There are no upcoming dividends for Enveric Biosciences.
Enveric Biosciences’s Q2 earnings are confirmed for Friday, August 9, 2024.
There is no upcoming split for Enveric Biosciences.
Enveric Biosciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.